Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL vs EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL vs EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL: Safety Overview

Metric EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL
Total FAERS Reports 18,558 211
Deaths Reported 429 7
Death Rate 2.3% 3.3%
Hospitalizations 1,627 33
Average Patient Age 48.7 yrs 37.2 yrs
% Female Patients 25.7% 59.4%